Status:
NOT_YET_RECRUITING
Expectant Moms Managing Attention-Deficit/ Hyperactivity Disorder
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
University of Maryland, College Park
Conditions:
ADHD
Perinatal
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The goal of this study is to test a behavioral program for pregnant individuals with ADHD. This behavioral program focuses on skills for managing ADHD and related symptoms in pregnancy and postpartum....
Detailed Description
Treating pregnant individuals with ADHD may improve parent and child wellbeing, parent-child interactions, and psychosocial familial factors to enhance family resilience and reduce prevalence/severity...
Eligibility Criteria
Inclusion
- meets full DSM-5 criteria for ADHD
- is between 14- and 22-weeks of gestation
- 18 years of age or older
- English speaking
- Lives in Pennsylvania
Exclusion
- substance use disorders requiring dual diagnosis treatment
- intellectual disability
- bipolar disorder, psychosis, and major depressive disorder with suicidal ideation
- the following high complexity medical conditions during pregnancy: maternal cancer, multiples, placenta accreta, and/or fetus known to have a severe congenital condition
Key Trial Info
Start Date :
February 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2028
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT07001293
Start Date
February 1 2026
End Date
May 31 2028
Last Update
December 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC Magee-Womens Hospital
Pittsburgh, Pennsylvania, United States, 15213